Results 131 to 140 of about 412,507 (379)

An Investigation of Hyperostosis Frontalis Interna in a Modern Anatomical Body Donor Population

open access: yesClinical Anatomy, EarlyView.
ABSTRACT This research sought to examine the prevalence and severity of hyperostosis frontalis interna (HFI) in the Chicagoland anatomical body donor population. The study further aimed to elucidate potential demographic risk factors for HFI, including sex, age at death, and structural vulnerability index (SVI), as well as any common comorbidities, as ...
Amy C. Beresheim, Amanda Hall
wiley   +1 more source

Pengetahuan Ibu Tentang Menopause Di Poliklinik Blu RSU Prof. Dr. R. D. Kandou Manado [PDF]

open access: yes, 2013
: The age of menopause in each women is different. When a women encounters the menopause, there will be a physiological and psychological change. If a women receive excellent information about menopause, the psychological change will appear minimal.
Batan, I. S. (Inri)   +2 more
core  

Discovery of the Postcoital Contraceptive Effect of Rhus pentaphylla in a Study of Acute, Subchronic, and Neurodevelopmental Toxicity of Ethanolic Leaf Extract

open access: yesChemistry &Biodiversity, EarlyView.
ABSTRACT In the present study, the acute, subchronic, and neurodevelopmental toxicity of Rhus pentaphylla, a Moroccan medicinal plant, was investigated in Swiss albino mice. HPLC analysis showed the presence of phenolic compounds with rutin as the principal component.
Fatimazahra Agouram   +4 more
wiley   +1 more source

Hubungan Antara Stadium Menopause Dengan Perubahan Seksual Wanita Menopause Di Posyandu Lansia Srikandi Kelurahan Sumbersari Kota Malang [PDF]

open access: yes, 2013
Hubungan Antara Stadium Menopause Dengan Perubahan Seksual Wanita Menopause Di Posyandu Lansia Srikandi Kelurahan Sumbersari Kota MalangCorrelation between Stadium of Menopause with the Alteration of Menopause Women'ssexuality in Posyandu of Srikandi's ...
Nugroho, Y. P. (Yuyus)
core  

Comparative Effect of African Walnut Oil and Docosahexaenoic Acid on, Cancer Antigen C15‐3, Biochemical and Histopathological Markers of Female Wistar Rats With 7,12‐Dimethylbenz[a]anthracene‐Induced Breast Cancer

open access: yesCancer Nexus, EarlyView.
ABSTRACT This work compares the effect of African walnut oil and docosahexaenoic acid (DHA) on cancer antigen C15‐3 (CA15‐3), biochemical, and histopathological markers of rats with 7,12‐dimethylbenz[a]anthracene‐induced (DMBA) breast cancer. 18 rats with tumor were randomized into three groups of six rats each: The negative control, the positive ...
Fabrice Tonfack Djikeng   +3 more
wiley   +1 more source

Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data

open access: yesThe Lancet Public Health, 2019
Summary: Background: Early menopause is linked to an increased risk of cardiovascular disease mortality; however, the association between early menopause and incidence and timing of cardiovascular disease is unclear.
Dongshan Zhu, MD   +26 more
doaj   +1 more source

Sexual Function and Factors Affecting Menopause: A Systematic Review

open access: yesJournal of Menopausal Medicine, 2019
The purpose of this review study is to evaluate sexual function and its effective factors in menopause. A systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
M. Heidari   +5 more
semanticscholar   +1 more source

Assessment of Pharmacokinetic Drug Interaction of Asciminib with Atorvastatin in Healthy Participants

open access: yesClinical Pharmacology in Drug Development, EarlyView.
Abstract Asciminib is the first BCR::ABL1 inhibitor that Specifically Targets the ABL Myristoyl Pocket (STAMP) in patients with chronic myeloid leukemia. This phase 1, two‐treatment‐period, drug‐drug interaction study evaluated the effect of steady‐state asciminib on the pharmacokinetics of atorvastatin.
Matthias Hoch   +9 more
wiley   +1 more source

Concentration–QTc Modeling to Support Clinical Development of Fezolinetant

open access: yesClinical Pharmacology in Drug Development, EarlyView.
Abstract Fezolinetant is a non‐hormonal, selective neurokinin‐3 receptor antagonist that blocks neurokinin B activation of kisspeptin/neurokinin B/dynorphin neurons to thereby modulate neuronal activity in the thermoregulatory center. Fezolinetant has been approved in many regions, including North America, Europe, Asia, and Australia for the treatment ...
Jace C. Nielsen   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy